Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Chinese Medical Journal|September 15, 2016
Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell CarcinomaDan Ma, Ye Zong, Sheng-Tao Zhu, et al.
Medicina (Kaunas, Lithuania)|May 27, 2026
Pharmacological Strategies for Preventing Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsWei Chen, Xin Tong, Yuhang Liu, et al.
International Journal of Colorectal Disease|October 24, 2019
EBV-associated lymphoproliferative disorder involving the gastrointestinal tract which mimic IBD in immunocompetent patients: case reports and literature reviewYanhua Zhou, Yanlin Zhang, Haiying Zhao, et al.
International Surgery|March 19, 2015
A case of recurrent Cronkhite-Canada syndrome containing colon cancerXi Zhu, Haiyun Shi, Xiaona Zhou, et al.
Gene|August 19, 2024
Identifying the importance of PCK1 in maintaining ileal epithelial barrier integrity in Crohn's diseaseDeyi Yang, Pengchong Li, Yan Dang, et al.
Frontiers in Oncology|October 3, 2022
Multiple rectal neuroendocrine tumors: An analysis of 15 cases and literature reviewShu Pang, Ye Zong, Kun Zhang, et al.
Journal of Inflammation Research|May 7, 2025
CD8<sup>+</sup> T Cell-Derived Perforin Exacerbates Dysbiosis and Inflammatory Bowel Disease via β-Hydroxybutyrate Suppression in Mouse Colonic EpitheliumShiyang Huang, Lehan Pan, Mingyang Li, et al.
Frontiers in Oncology|March 30, 2023
Case report: Coexistence of sigmoid tumor with unusual pathological features and multiple colorectal neuroendocrine tumors with lymph node metastasesShu Pang, Jiugang Song, Kun Zhang, et al.
BMC Gastroenterology|October 25, 2024
Risk of Clostridioides difficile infection in inflammatory bowel disease patients undergoing vedolizumab treatment: a systematic review and meta-analysisWei Chen, Yuhang Liu, Yuelun Zhang, et al.
Current Medical Research and Opinion|October 8, 2024
Efficacy and safety of tegoprazan for duodenal ulcers in Chinese patients: a multicenter, randomized, double-blind, non-inferiority, phase III studyYe Zong, Cheng Lan, Xing Li, et al.
Pageof 5